Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Optical High Content Nanoscopy of Epigenetic Marks Decodes Phenotypic Divergence in Stem Cells.

Kim JJ, Bennett NK, Devita MS, Chahar S, Viswanath S, Lee EA, Jung G, Shao PP, Childers EP, Liu S, Kulesa A, Garcia BA, Becker ML, Hwang NS, Madabhushi A, Verzi MP, Moghe PV.

Sci Rep. 2017 Jan 4;7:39406. doi: 10.1038/srep39406.

2.

Vascularization of three-dimensional engineered tissues for regenerative medicine applications.

Kim JJ, Hou L, Huang NF.

Acta Biomater. 2016 Sep 1;41:17-26. doi: 10.1016/j.actbio.2016.06.001. Epub 2016 Jun 2. Review.

PMID:
27262741
3.

Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.

Hou L, Kim JJ, Woo YJ, Huang NF.

Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H455-65. doi: 10.1152/ajpheart.00726.2015. Epub 2015 Dec 18. Review.

4.

VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus.

Fagone P, Muthumani K, Mangano K, Magro G, Meroni PL, Kim JJ, Sardesai NY, Weiner DB, Nicoletti F.

Immunology. 2014 Aug;142(4):594-602. doi: 10.1111/imm.12267.

5.

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.

Shedlock DJ, Tingey C, Mahadevan L, Hutnick N, Reuschel EL, Kudchodkar S, Flingai S, Yan J, Kim JJ, Ugen KE, Weiner DB, Muthumani K.

Vaccines (Basel). 2014 Mar 25;2(2):196-215. doi: 10.3390/vaccines2020196.

6.

A high content imaging-based approach for classifying cellular phenotypes.

Kim JJ, Vega SL, Moghe PV.

Methods Mol Biol. 2013;1052:41-8. doi: 10.1007/7651_2013_29.

7.

Microfibrous substrate geometry as a critical trigger for organization, self-renewal, and differentiation of human embryonic stem cells within synthetic 3-dimensional microenvironments.

Carlson AL, Florek CA, Kim JJ, Neubauer T, Moore JC, Cohen RI, Kohn J, Grumet M, Moghe PV.

FASEB J. 2012 Aug;26(8):3240-51. doi: 10.1096/fj.11-192732. Epub 2012 Apr 27.

8.

Interconnected contribution of tissue morphogenesis and the nuclear protein NuMA to the DNA damage response.

Vidi PA, Chandramouly G, Gray M, Wang L, Liu E, Kim JJ, Roukos V, Bissell MJ, Moghe PV, Lelièvre SA.

J Cell Sci. 2012 Jan 15;125(Pt 2):350-61. doi: 10.1242/jcs.089177. Epub 2012 Feb 13.

9.

Skeletal stem cell physiology on functionally distinct titania nanotopographies.

McNamara LE, Sjöström T, Burgess KE, Kim JJ, Liu E, Gordonov S, Moghe PV, Meek RM, Oreffo RO, Su B, Dalby MJ.

Biomaterials. 2011 Oct;32(30):7403-10. doi: 10.1016/j.biomaterials.2011.06.063. Epub 2011 Aug 4.

PMID:
21820172
10.

DNA-based influenza vaccines: evaluating their potential to provide universal protection.

Choo AY, Broderick KE, Kim JJ, Sardesai NY.

IDrugs. 2010 Oct;13(10):707-12. Review.

PMID:
20878593
11.

Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.

Muthumani K, Lankaraman KM, Laddy DJ, Sundaram SG, Chung CW, Sako E, Wu L, Khan A, Sardesai N, Kim JJ, Vijayachari P, Weiner DB.

Vaccine. 2008 Sep 19;26(40):5128-34. doi: 10.1016/j.vaccine.2008.03.060. Epub 2008 Apr 14.

12.

Cancer vaccines: is the future now?

Weiner DB, Kim JJ.

Expert Rev Vaccines. 2002 Oct;1(3):257-60.

PMID:
12901565
13.

Issues for improving multiplasmid DNA vaccines for HIV-1.

Muthumani K, Kudchodkar S, Zhang D, Bagarazzi ML, Kim JJ, Boyer JD, Ayyavoo V, Pavlakis GN, Weiner DB.

Vaccine. 2002 May 6;20(15):1999-2003. Review.

PMID:
11983262

Supplemental Content

Loading ...
Support Center